GTG 0.00% 3.9¢ genetic technologies limited

Is the product release date, come rollout date today?"Genetic...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 3,088 Posts.
    lightbulb Created with Sketch. 48
    Is the product release date, come rollout date today?

    "Genetic Technologies Limited (ASX Code: GTG; NASDAQ Ticker:GENE) announces successful completion of two new groundbreakingGenetic Risk Tests – for Colorectal Cancer and for BreastCancer - 10 May 2019Genetic Technologies Limited (ASX: GTG; NASDAQ Ticker: GENE) is delighted to announce that followingsubstantial scientific research and genetic product development, two new ground-breaking cancer riskassessment tests have now been completed and validated."

    Nothing new from the above here?


    "GTG intends to introduce the new ‘GeneType for Colorectal Cancer’ and ‘GeneType for Breast Cancer’genetic tests to healthcare providers through a global network of distribution partners. The Company hasalready announced it is working with TGen in the United States and also Chinese partners connected to theHainan Free-Trade Zone. More announcements are anticipated in this regard in coming months as GTG movesto commercialise its suite of world-leading genetic tests."

    .
 
watchlist Created with Sketch. Add GTG (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.